Trials / Completed
CompletedNCT04144751
Blood Collection Sub-Study of Exact Sciences Protocol 2019-01: "Clinical Validation of an Optimized Multi-Target Stool DNA (Mt-sDNA 2.0) Test, For Colorectal Cancer Screening BLUE-C"
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 23,494 (actual)
- Sponsor
- Exact Sciences Corporation · Industry
- Sex
- All
- Age
- 40 Years
- Healthy volunteers
- Accepted
Summary
The primary objective of this sub-study, 2019-01B, is to collect blood specimens for research use in the development and validation of a blood-based test for colorectal cancer (CRC).
Detailed description
Subjects who consent to enroll in Exact Sciences Protocol 2019-01 BLUE-C, will be invited to participate in this sub-study. Subjects enrolled in the Exact Sciences Protocol 2019-01 BLUE-C, who provide written informed consent to participate in this sub-study, will have a blood sample collected at enrollment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Blood Sample Collection | Subjects participating in the study will have blood drawn at enrollment. |
Timeline
- Start date
- 2019-11-15
- Primary completion
- 2023-03-30
- Completion
- 2023-03-30
- First posted
- 2019-10-30
- Last updated
- 2023-09-28
Locations
194 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT04144751. Inclusion in this directory is not an endorsement.